Stock data

生泰 (1777)

生泰 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$132.85M, up 22.1% from a year earlier. EPS over the last four quarters totals NT$7.44.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 生泰 in Insightr